Charles River Labs Intl buy JPMorgan Chase & Co.
Start price
20.12.23
/
50%
€211.90
Target price
20.12.24
€246.65
Performance (%)
0.19%
Price
25.04.24
€212.30
Summary
This prediction is currently active. Since the start of the prediction for Charles River Labs Intl the price has only changed by 0.19%. This prediction currently runs until 20.12.24. The prediction end date can be changed by JPMorgan_Chase___Co_ at any time. JPMorgan_Chase___Co_ has 50% into this predictionPerformance without dividends (%)
Name | 1w | 1m |
---|---|---|
Charles River Labs Intl | -0.235% | -0.235% |
iShares Core DAX® | 2.594% | -1.158% |
iShares Nasdaq 100 | 3.553% | -1.727% |
iShares Nikkei 225® | 0.687% | -8.354% |
iShares S&P 500 | 2.209% | -0.942% |
Comments by JPMorgan_Chase___Co_ for this prediction
In the thread Charles River Labs Intl diskutieren
Charles River Laboratories International, Inc. (NYSE: CRL) had its price target raised by analysts at JPMorgan Chase & Co. from $210.00 to $270.00. They now have an "overweight" rating on the stock.
Ratings data for CRL provided by MarketBeat
Stopped prediction by JPMorgan_Chase___Co_ for Charles River Labs Intl
Charles River Labs Intl
Start price
Target price
Perf. (%)
€227.80
15.02.24
15.02.24
€259.70
15.02.25
15.02.25
-6.80%
25.04.24
25.04.24
Charles River Labs Intl
Start price
Target price
Perf. (%)
€198.20
10.08.23
10.08.23
€227.00
10.08.24
10.08.24
7.11%
25.04.24
25.04.24